Hjem › Epitelcellekarcinom i eggstokkene › Massachusetts
Kliniske studier for Epitelcellekarcinom i eggstokkene i Massachusetts
9 studier for Epitelcellekarcinom i eggstokkene søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
A Study of Isoquercetin in People With Ovarian Cancer
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07303894AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, Burlington
- Research Site, Worcester
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 21. jul. 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 2. jul. 2026 · NCT06819007A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0104, Boston
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 7. apr. 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Massachusetts General Hospital, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Massachusetts General Hospital, Boston
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 3. feb. 2026 · NCT06469281CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Massachusetts General Hospital, Boston
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 23. des. 2025 · NCT06690775Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
- Massachusetts General Hospital, Boston
RekruttererObservasjonsstudie
Alder 30 og eldre · Kvinner · Oppdatert 16. sep. 2025 · NCT04794322Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Dana Farber/Partners Cancer Care Inc, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. aug. 2025 · NCT04429542Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.